What's new

Nilotinib product-specific bioequivalence guidance

Nilotinib product-specific bioequivalence guidance

Feb 12, 2025 - 09:34
 0
Nilotinib product-specific bioequivalence guidance
Nilotinib product-specific bioequivalence guidance
Read More

Tags:

Previous Article

DB signs major digitalisation contract EUR 6.3 billion

Next Article

Overview of comments received on `Nilotinib hard capsules 50, 150 and 200 mg pro...

Related Posts

Conduct of efficacy studies for intramammary products for use in cattle - Scientific guideline

Conduct of efficacy studies for intramammary products f...

Feb 21, 2025  0

Training on human variations web-based electronic application form (eAF) functionalities for non-CAPs variations, Online, European Medicines Agency, Amsterdam, the Netherlands, from 11 February 2025, 10:30 (CET) to 11 February 2025, 12:30 (CET)

Training on human variations web-based electronic appli...

Feb 9, 2025  0

Human medicines European public assessment report (EPAR): Hukyndra, adalimumab, Date of authorisation: 15/11/2021, Revision: 9, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 9, 2025  0